American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
Acute intrahepatic lymphangiectasia following liver transplantation: An underrecognized potential etiology for biliary and portal vein stenosis.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ma Yu, Wu Shuai, Liu Danqing, Li Guangyao, Zhang Shiran, Zhou Bo, Chen Ping, Chen Geng
Аннотация
Acute intrahepatic lymphangiectasia (IHL) is a pathologic condition characterized by abnormal dilation of the intrahepatic lymphatic vessels and related lymphedema, often resulting from impaired lymphatic drainage. Iatrogenic/non-iatrogenic abdominal injury and hepatic malignant neoplasms are the most common etiology of IHL. It is relatively common following liver transplantation, typically due to surgical manipulation or transient obstruction. In most cases, it is self-limiting and asymptomatic, requiring no specific intervention. To date, there have been no reports of IHL causing severe complications graded Clavien-Dindo III or higher. We report a case of acute IHL following liver transplantation that induced biliary and portal vein stenosis in the graft liver. This 51-year-old male patient with hepatitis B virus-related hepatocellular carcinoma developed acute IHL in the early posttransplant period, presenting with elevated alanine aminotransferase and bilirubin, diagnosed through imaging findings and cyst fluid analysis. Interventions included cyst aspiration, endoscopic biliary stenting, and percutaneous portal vein stenting due to biliary obstruction and portal vein stenosis. Liver function normalized, leading to discharge on postoperative day 60. At 5-month follow-up, imaging confirmed restored vascular and biliary patency, with sustained normal function over 8 months.